ITGAM and melanoma: In melanoma-bearing mice, blocking CCR5/CCL5 interaction by mCCR5-Ig [104] reduces the migration and immunosuppressive potential of PMN-MDSCs (CD11b+Ly6G+Ly6Clo), resulting in increased survival [95].